SEC Comment Letter 0000000000-23-006884 to GENELUX Corp (GNLX)
GENELUX Corp
Date: June 28, 2023 · CIK: 0001231457 · Accession: 0000000000-23-006884
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272966
Letter
United States securities and exchange commission logo June 28, 2023 Thomas Zindrick, J.D. President and Chief Executive Officer Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village, California 91361 Re:Genelux Corporation Registration Statement on Form S-1 Filed June 28, 2023 File No. 333-272966 Dear Thomas Zindrick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Terren J. O’Connor
Show Raw Text
United States securities and exchange commission logo
June 28, 2023
Thomas Zindrick, J.D.
President and Chief Executive Officer
Genelux Corporation
2625 Townsgate Road, Suite 230
Westlake Village, California 91361
Re:Genelux Corporation
Registration Statement on Form S-1
Filed June 28, 2023
File No. 333-272966
Dear Thomas Zindrick:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Terren J. O’Connor